Lukas Biomedical Inc. (TPEX:6814)
18.85
-0.85 (-4.31%)
Nov 20, 2026, 1:19 PM CST
Lukas Biomedical Market Cap
Lukas Biomedical has a market cap or net worth of 789.33 million as of November 20, 2026. It is the 35,012th most valuable company in the world and the 2,077th biggest in Taiwan. Its market cap has decreased by 34.78% in one year.
Market Cap
789.33M
Enterprise Value
1.01B
Revenue
170.01M
Global Rank
Country Rank
#2,077 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 31, 2020, Lukas Biomedical's market cap has decreased from 1.78B to 789.33M, a decrease of -55.54%. That is a compound annual growth rate of -12.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 789.33M | -39.19% |
| Dec 31, 2025 | 1.30B | 3.85% |
| Dec 31, 2024 | 1.25B | 15.69% |
| Dec 29, 2023 | 1.08B | -6.98% |
| Dec 30, 2022 | 1.16B | -15.47% |
| Dec 30, 2021 | 1.37B | -22.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio Preventive Medicine | 959.30M |
| Level Biotechnology | 921.66M |
| BiOptic | 866.92M |
| TCI GENE | 859.92M |
| Sunny Pharmtech | 842.23M |
| Holy Stone Healthcare | 759.06M |
| BioLASCO Taiwan | 718.42M |
| GeneReach Biotechnology | 693.67M |